ATTR Amyloidosis Wild Type: Clinical Trials

8 trials for ATTR Amyloidosis Wild Type, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 3 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow ATTR Amyloidosis Wild Type: new trials by email Literature Review of ATTR Amyloidosis Wild Type trials Research Report on ATTR Amyloidosis Wild Type

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
ATTR Amyloidosis With Cardiomyopathy, ATTR-CM
RecruitingMedical University of Vienna6002025-01-012025-02-19
EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM)
mHealth - Heart Failure, Amyloid Cardiomyopathy
Not applicableUnknownHospital Universitari de Bellvitge502024-12-012024-10-23
ATTR Cardiac Amyloidosis in a Selected Population
ATTR Amyloidosis Wild Type, ATTR Gene Mutation
RecruitingHelse Møre og Romsdal HF1802024-09-012026-08-12
Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
Dobutrex - ATTR Amyloidosis Wild Type
Phase 1 / Phase 2RecruitingSteen Hvitfeldt Poulsen152024-04-082026-06-01
Amyloidosis Incidence in High-Risk Cardiac Device Patients
Chest Wall Fat Tissue Collection - Amyloid, Cardiac Amyloidosis
UnknownMidwest Heart & Vascular Specialists1002024-01-292024-02-20
NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis
Amyloidosis, Amyloidosis Cardiac
RecruitingPaolo Milani2002024-01-262026-04-16
Prevalence of ATTR Cardiac Amyloidosis in Patients Undergoing TAVR
ATTR Amyloidosis Wild Type, Severe Aortic Stenosis
UnknownJordan Collaborating Cardiology Group1002023-10-012023-08-29
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Tc99-PYP or Tc99-HDMP Scan - Lumbar Spinal Stenosis, Cardiac Amyloidosis
RecruitingColumbia University16632023-09-192026-06-04

Narrower conditions

Amyloid Neuropathies, Familial (6)  ·  Alzheimer Disease (1)  ·  Amyloidosis (1)  ·  Aortic Valve Stenosis (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Carpal Tunnel Syndrome (1)  ·  Heart Failure (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)  ·  Mitral Valve Insufficiency (1)  ·  Spinal Stenosis (1)  ·  Tricuspid Valve Insufficiency (1)

Broader conditions

Amyloid Neuropathies (6)  ·  Amyloidosis, Familial (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Genetic Diseases, Inborn (6)  ·  Heredodegenerative Disorders, Nervous System (6)  ·  Metabolic Diseases (6)  ·  Metabolism, Inborn Errors (6)  ·  Nervous System Diseases (6)  ·  Neurodegenerative Diseases (6)  ·  Neuromuscular Diseases (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Peripheral Nervous System Diseases (6)  ·  Proteostasis Deficiencies (6)  ·  Amyloidosis (5)  ·  Cardiovascular Diseases (4)

Interventions

Dobutamine (1)  ·  Telemedicine (1)

Sponsors

Columbia University (1)  ·  Helse Møre og Romsdal HF (1)  ·  Hospital Universitari de Bellvitge (1)  ·  Jordan Collaborating Cardiology Group (1)  ·  Medical University of Vienna (1)  ·  Midwest Heart & Vascular Specialists (1)  ·  Paolo Milani (1)  ·  Steen Hvitfeldt Poulsen (1)

Countries

Italy (2)  ·  United States (2)  ·  Austria (1)  ·  Denmark (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Norway (1)

Top investigators

Mathew S Maurer, MD (1)  ·  Sergi Yun Viladomat, MD (1)  ·  Torstein Hole, MD, PhD (1)  ·  Vasvi Singh, MD (1)

Results publications

PMID 42866868

NIH funding

2023 (1), R01AG081582 (1)